Fort Washington Investment Advisors Inc. OH Acquires 92,984 Shares of Option Care Health, Inc. $OPCH

Key Points

• Fort Washington Investment Advisors Inc. increased its stake in Option Care Health, acquiring an additional 92,984 shares, raising its total holdings to 883,404 shares worth approximately $28.7 million.
• Several institutional investors, including Northwestern Mutual Wealth Management Co. and Bessemer Group Inc., have significantly boosted their investments in Option Care Health, indicating increased confidence in the company.
• Analysts have given Option Care Health a consensus rating of "Moderate Buy", with a target price around $35.75, reflecting positive sentiment towards the company's performance and growth potential.

Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 11.8% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 883,404 shares of the company's stock after purchasing an additional 92,984 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.54% of Option Care Health worth $28,693,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after buying an additional 836 shares during the last quarter. Brooklyn Investment Group raised its stake in Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares during the last quarter. Bessemer Group Inc. boosted its holdings in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares during the period. Finally, Wealthquest Corp acquired a new stake in Option Care Health in the 1st quarter worth $66,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Analyst Ratings Changes

OPCH has been the subject of a number of research analyst reports. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Tuesday, September 23rd. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $35.75.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The stock was acquired at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director directly owned 375,390 shares of the company's stock, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Timothy P. Sullivan purchased 20,000 shares of Option Care Health stock in a transaction on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the transaction, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 59,411 shares of company stock valued at $1,627,576. 0.64% of the stock is owned by insiders.

Option Care Health Stock Up 1.8%

Shares of OPCH opened at $27.30 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The company has a 50-day moving average price of $28.57 and a two-hundred day moving average price of $31.01. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of 21.84, a P/E/G ratio of 1.66 and a beta of 0.83. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same period in the prior year, the firm posted $0.30 EPS. Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.